Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension (TRUST-1)

This study has been terminated.
(Safety issues related to outpatient intravenous infusion in India)
Asian Clinical Trials
Information provided by (Responsible Party):
United Therapeutics Identifier:
First received: June 27, 2007
Last updated: January 28, 2014
Last verified: January 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2005
  Primary Completion Date: October 2005 (Final data collection date for primary outcome measure)
No publications provided by United Therapeutics

Publications automatically indexed to this study by Identifier (NCT Number):